EE200100329A - Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod - Google Patents
Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetodInfo
- Publication number
- EE200100329A EE200100329A EEP200100329A EEP200100329A EE200100329A EE 200100329 A EE200100329 A EE 200100329A EE P200100329 A EEP200100329 A EE P200100329A EE P200100329 A EEP200100329 A EE P200100329A EE 200100329 A EE200100329 A EE 200100329A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- benzisoxazoles
- phenones
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98204358 | 1998-12-21 | ||
PCT/EP1999/010054 WO2000037466A1 (en) | 1998-12-21 | 1999-12-14 | BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200100329A true EE200100329A (et) | 2002-08-15 |
Family
ID=8234508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100329A EE200100329A (et) | 1998-12-21 | 1999-12-14 | Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod |
Country Status (30)
Country | Link |
---|---|
US (1) | US6576640B1 (ja) |
EP (1) | EP1140934B1 (ja) |
JP (1) | JP4717216B2 (ja) |
KR (2) | KR20060093139A (ja) |
CN (1) | CN1154646C (ja) |
AR (1) | AR021924A1 (ja) |
AT (1) | ATE251622T1 (ja) |
AU (1) | AU765751B2 (ja) |
BG (1) | BG65162B1 (ja) |
BR (1) | BR9916427A (ja) |
CA (1) | CA2355716C (ja) |
CZ (1) | CZ294532B6 (ja) |
DE (1) | DE69911995T2 (ja) |
EA (1) | EA003606B1 (ja) |
EE (1) | EE200100329A (ja) |
ES (1) | ES2209553T3 (ja) |
HK (1) | HK1045686B (ja) |
HR (1) | HRP20010444A2 (ja) |
HU (1) | HUP0104812A3 (ja) |
ID (1) | ID28967A (ja) |
IL (2) | IL143830A0 (ja) |
NO (1) | NO317892B1 (ja) |
NZ (1) | NZ511411A (ja) |
PL (1) | PL196958B1 (ja) |
SK (1) | SK285560B6 (ja) |
TR (1) | TR200101813T2 (ja) |
TW (1) | TWI229673B (ja) |
UA (1) | UA71938C2 (ja) |
WO (1) | WO2000037466A1 (ja) |
ZA (1) | ZA200105067B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04000036A (es) | 2001-07-05 | 2004-05-21 | Upjohn Co | Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht. |
AU2003219199A1 (en) * | 2002-04-03 | 2003-10-13 | Orion Corporation | Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
EP1757605A4 (en) | 2004-04-12 | 2007-12-19 | Taisho Pharmaceutical Co Ltd | CYCLIC AMINE COMPOUND |
CN101268075A (zh) * | 2005-07-28 | 2008-09-17 | 百时美施贵宝公司 | 作为5-羟色胺受体激动剂和拮抗剂的取代的四氢-1h吡啶并[4,3,b]吲哚 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3419568A (en) * | 1966-12-07 | 1968-12-31 | Abbott Lab | Derivatives of 1,2,3,4-tetrahydro-5h-pyrido[4,3b]indoles |
US3382250A (en) * | 1966-12-07 | 1968-05-07 | Abbott Lab | Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles |
US3718657A (en) * | 1970-12-03 | 1973-02-27 | Abbott Lab | Certain-2-substituted-1,2,3,4-tetrahydro-beta or gamma carbolines |
JPS4729395U (ja) * | 1971-04-26 | 1972-12-04 | ||
AR206812A1 (es) * | 1974-04-01 | 1976-08-23 | Pfizer | Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica |
US4001263A (en) * | 1974-04-01 | 1977-01-04 | Pfizer Inc. | 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines |
US4224329A (en) * | 1979-01-23 | 1980-09-23 | Pfizer Inc. | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles |
FR2570701B1 (fr) * | 1984-09-27 | 1987-05-22 | Synthelabo | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique |
DE3522959A1 (de) * | 1985-06-27 | 1987-01-08 | Merck Patent Gmbh | Indolderivate |
EP0339959A3 (en) * | 1988-04-27 | 1991-03-20 | Glaxo Group Limited | Lactam derivatives |
WO1994008040A1 (en) * | 1992-09-25 | 1994-04-14 | Synaptic Pharmaceutical Corporation | Dna encoding human alpha 1 adrenergic receptors and uses thereof |
US5403847A (en) | 1992-11-13 | 1995-04-04 | Synaptic Pharmaceutical Corporation | Use of α1C specific compounds to treat benign prostatic hyperlasia |
US5508306A (en) * | 1992-11-13 | 1996-04-16 | Synaptic Pharmaceutical Corporation | Aromatic amine derivatives |
UA52681C2 (uk) * | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
-
1999
- 1999-12-14 US US09/868,756 patent/US6576640B1/en not_active Expired - Lifetime
- 1999-12-14 CZ CZ20012120A patent/CZ294532B6/cs not_active IP Right Cessation
- 1999-12-14 UA UA2001064352A patent/UA71938C2/uk unknown
- 1999-12-14 KR KR1020067015507A patent/KR20060093139A/ko not_active Application Discontinuation
- 1999-12-14 HU HU0104812A patent/HUP0104812A3/hu unknown
- 1999-12-14 WO PCT/EP1999/010054 patent/WO2000037466A1/en not_active Application Discontinuation
- 1999-12-14 DE DE69911995T patent/DE69911995T2/de not_active Expired - Lifetime
- 1999-12-14 SK SK858-2001A patent/SK285560B6/sk unknown
- 1999-12-14 ES ES99967955T patent/ES2209553T3/es not_active Expired - Lifetime
- 1999-12-14 BR BR9916427-2A patent/BR9916427A/pt not_active Application Discontinuation
- 1999-12-14 ID IDW00200101335A patent/ID28967A/id unknown
- 1999-12-14 CA CA2355716A patent/CA2355716C/en not_active Expired - Fee Related
- 1999-12-14 NZ NZ511411A patent/NZ511411A/xx unknown
- 1999-12-14 EA EA200100709A patent/EA003606B1/ru not_active IP Right Cessation
- 1999-12-14 TR TR2001/01813T patent/TR200101813T2/xx unknown
- 1999-12-14 IL IL14383099A patent/IL143830A0/xx active IP Right Grant
- 1999-12-14 AT AT99967955T patent/ATE251622T1/de not_active IP Right Cessation
- 1999-12-14 CN CNB998147095A patent/CN1154646C/zh not_active Expired - Fee Related
- 1999-12-14 JP JP2000589537A patent/JP4717216B2/ja not_active Expired - Fee Related
- 1999-12-14 EP EP99967955A patent/EP1140934B1/en not_active Expired - Lifetime
- 1999-12-14 AU AU24327/00A patent/AU765751B2/en not_active Ceased
- 1999-12-14 EE EEP200100329A patent/EE200100329A/xx unknown
- 1999-12-14 KR KR1020017004946A patent/KR100657540B1/ko not_active IP Right Cessation
- 1999-12-14 PL PL348421A patent/PL196958B1/pl unknown
- 1999-12-16 TW TW088122067A patent/TWI229673B/zh not_active IP Right Cessation
- 1999-12-20 AR ARP990106577A patent/AR021924A1/es active IP Right Grant
-
2001
- 2001-05-18 BG BG105521A patent/BG65162B1/bg unknown
- 2001-06-06 NO NO20012783A patent/NO317892B1/no unknown
- 2001-06-14 HR HR20010444A patent/HRP20010444A2/hr not_active Application Discontinuation
- 2001-06-19 IL IL143830A patent/IL143830A/en not_active IP Right Cessation
- 2001-06-20 ZA ZA200105067A patent/ZA200105067B/en unknown
-
2002
- 2002-07-09 HK HK02105098.8A patent/HK1045686B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04739B1 (et) | Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod | |
DE69939959D1 (de) | Polymer, Verfahren zu seiner Herstellung und Zusammensetzung | |
GB9903216D0 (en) | Preservative compounds,compositions and methods of making and using the same | |
EE200100437A (et) | C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine | |
DE69918871D1 (de) | Zementzusatzmittel und Zementzusammensetzung | |
EE200000621A (et) | Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine | |
FI962908A (fi) | Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö | |
EE04490B1 (et) | Ühend, selle valmistamise meetod ning kasutamine meditsiinis | |
EE200100653A (et) | Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine | |
ID30238A (id) | Komposisi-komposisi amifostin amorf yang stabil dan metode-metode untuk pembuatan dan penggunaannya | |
ITMI20000701A0 (it) | Composizione di gomma procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma | |
DK1140824T3 (da) | Fremgangsmåde til fremstilling af 3-alkanoyl- og 3-alkylindoler | |
EE03682B1 (et) | Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine | |
EE04087B1 (et) | Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode | |
EE200100314A (et) | Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine | |
EE200000767A (et) | Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon | |
EE03554B1 (et) | Mikropoorne kristalne materjal, selle valmistamismeetod ja kasutamine detergentkompositsioonides | |
EE05187B1 (et) | Hirudiini prekursor, selle kasutamine ja meetod Leu-hirudiini valmistamiseks | |
DE60028757D1 (de) | Polyolefinzusammensetzung, verfahren zur herstellung und die verwendung davon | |
EE04770B1 (et) | Tritsüklilised delta3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod | |
EE200100329A (et) | Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod | |
EE200100305A (et) | Preparaat, selle kasutamine ja valmistamismeetod | |
DK1061955T3 (da) | Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf | |
EE9900152A (et) | Poorne kattepigment ning selle valmistamismeetod | |
EE9900311A (et) | Söödalisandi valmistamise meetod, söödalisand ja selle kasutamine |